| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,325,900 | 1,193,400 | 926,700 | 1,193,100 | | Cost of Revenue | 1,087,100 | 1,007,000 | 846,400 | 1,051,200 | | | Gross Profit | 238,800 | 186,400 | 80,300 | 141,900 | | | Operating Expenses | | Research Development | 82,700 | 84,000 | 75,200 | 63,800 | | Selling General and Administrative | 90,400 | 108,900 | 88,000 | 99,500 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 5,700 | 5,800 | 5,800 | 5,900 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 60,000 | (12,300) | (88,700) | (27,300) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,900) | 900 | 2,700 | 4,200 | | Earnings Before Interest And Taxes | 57,500 | (10,300) | (85,100) | (22,600) | | Interest Expense | 18,300 | 17,600 | 18,400 | 24,000 | | Income Before Tax | 39,200 | (27,900) | (103,500) | (46,600) | | Income Tax Expense | 5,500 | (7,400) | (39,400) | (8,900) | | Minority Interest | (500) | 500 |
-
| (700) | | | | Net Income From Continuing Ops | 33,200 | (20,000) | (64,100) | (38,400) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 33,200 | (20,000) | (64,100) | (38,400) | | Preferred Stock And Other Adjustments | (400) | (700) | 700 |
-
| | | Net Income Applicable To Common Shares | $32,800 | ($20,700) | ($63,400) | ($38,400) |
|
1.52% Nasdaq 
Income Statement
